swapnil hiremath

April 14, 2025

Background

Metformin- Should I Stay or Should I Go

swapnil hiremath

April 14, 2025

Background

This week, we will discuss another target trial emulation study. The FDA says to stop metformin at a GFR of 30. Are they right?

swapnil hiremath

January 21, 2025

Background

HOPE-ing and Coping with Pain in Dialysis

swapnil hiremath

January 21, 2025

Background

HOPE-ing and Coping with Pain in Dialysis

This week, we will discuss the HOPE trial - no not that one - the one in dialysis that was a LBCT in 2024. Should we look beyond analgesics to non-pharmacological options more seriously?

swapnil hiremath

December 2, 2024

Background

BPROAD: Sprinting down the BP Road in Diabetes

swapnil hiremath

December 2, 2024

Background

BPROAD: Sprinting down the BP Road in Diabetes

This week, we will discuss hopefully the final story of intensive BP lowering. BPROAD is a larger version of ACCORD without the glycemic control arm. Dive in.

swapnil hiremath

November 12, 2024

news

The BlueSky Migration

swapnil hiremath

November 12, 2024

news

What is BlueSky and why should you migrate? Because winter…is coming!

swapnil hiremath

October 29, 2024

news

Making Kidney Health a Global Priority

swapnil hiremath

October 29, 2024

news

Let’s push the WHO to make Kidney Health a global priority

swapnil hiremath

October 8, 2024

Commentary

Finerenone Finally Finishing off Spironolactone?

swapnil hiremath

October 8, 2024

Commentary

Finerenone Finally Finishing off Spironolactone?

A commentary putting the recent finerenone and spironolactone trials in perspective

swapnil hiremath

August 5, 2024

Background

Trial by Combat: Do Amino Acids provide PROTECTION to the Kidneys?

swapnil hiremath

August 5, 2024

Background

Trial by Combat: Do Amino Acids provide PROTECTION to the Kidneys?

This week, we will discuss an intriguing hypothesis for many nephrologists: can amino acids prevent acute kidney injury?

swapnil hiremath

July 8, 2024

Background

Mapping the course of rare renal diseases with RaDaR

swapnil hiremath

July 8, 2024

Background

Mapping the course of rare renal diseases with RaDaR

This week, we will discuss the RaDaR study. Does rare mean kidney failure occurs rarely? What are rare diseases? Do we see them in children more than adults? All this and more!

swapnil hiremath

June 11, 2024

Commentary

FLOW Trial: Are Innovative Treatments Accessible to the Patient Communities in Need?`

swapnil hiremath

June 11, 2024

Commentary

FLOW Trial: Are Innovative Treatments Accessible to the Patient Communities in Need?`

We have a patient voice feature back on the FLOW trial from Kevin Fowler.

swapnil hiremath

June 11, 2024

Background

FLOWing with the SemagluTIDE

swapnil hiremath

June 11, 2024

Background

This week, we will discuss the blockbuster trial of 2024, FLOW. GLP1RAs have arrived in the nephrology realm.

swapnil hiremath

May 7, 2024

Background

The KDIGO CKD 2024 Guidelines Part 1: Evaluation and Risk Stratification

swapnil hiremath

May 7, 2024

Background

The KDIGO CKD 2024 Guidelines Part 1: Evaluation and Risk Stratification

This week, we will discuss the 2024 KDIGO Guidelines on CKD, part 1. In this section we will discuss the first two chapters on CKD evaluation and risk stratification. Let’s dive in!

swapnil hiremath

April 9, 2024

Background

Healing, Hype, or Harm: The NefIgArd trial

swapnil hiremath

April 9, 2024

Background

Healing, Hype, or Harm: The NefIgArd trial

This week, we will discuss the final results of the NEFIGARD trial with the GFR slope data. Is targeted release budesonide aka Nefecon really a way to provide steroid efficacy without steroid side effects?

swapnil hiremath

March 12, 2024

Background

The Worldwide Shadow of Kidney Disease

swapnil hiremath

March 12, 2024

Background

This week, during kidney month and NephMadness season, we will discuss the USRDS report as well as the ISN Global Kidney Health Atlas report from 2024.

swapnil hiremath

March 10, 2024

Background

The PROTECT-V platform - RENALISM no more?

swapnil hiremath

March 10, 2024

Background

The PROTECT-V platform - RENALISM no more?

This week on NephTrials we will discuss the PROTECT-V trial, a platform trial for preventing COVID-19 infections in the vulnerable kidney populations.

swapnil hiremath

February 20, 2024

Background

Dialysis dreams and sleepless realities: the SLEEP-HD trial

swapnil hiremath

February 20, 2024

Background

Dialysis dreams and sleepless realities: the SLEEP-HD trial

This week, we will discuss the SLEEP-HD trial, which examined if trazodone or CBT are better than placebo in helping people sleep.

swapnil hiremath

February 3, 2024

Background

Hungry Like The Wolf for New Lupus Nephritis Guidance

swapnil hiremath

February 3, 2024

Background

Hungry Like The Wolf for New Lupus Nephritis Guidance

This week, we will discuss the recently published KDIGO lupus guidelines. Published a couple of years after the big GN guidelines - let us dive in to see what’s new in lupus nephritis

swapnil hiremath

January 23, 2024

Background

Is Eculizumab a good Complement in STEC-HUS?

swapnil hiremath

January 23, 2024

Background

Is Eculizumab a good Complement in STEC-HUS?

This week, we will be discussing a randomized controlled trial of eculizumab in STEC-HUS. Will eculizumab manage to surpass its well-established reputation as expensivumab and demonstrate some positive results?

swapnil hiremath

January 9, 2024

Background

Two’s Company but Three maybe the Winner? Aldosterone Synthase Inhibition added to RASi + Flozin

swapnil hiremath

January 9, 2024

Background

Two’s Company but Three maybe the Winner? Aldosterone Synthase Inhibition added to RASi + Flozin

This week we will discuss the article from Lancet on the addition of an ASI to background RASi and empagliflozin. Did this work?

swapnil hiremath

January 2, 2024

news

Which were the Top Nephrology Stories of 2023?

swapnil hiremath

January 2, 2024

news

Which were the Top Nephrology Stories of 2023?

Time to vote for the Top Stories of 2023

swapnil hiremath

December 5, 2023

Visual Abstract

ZENITH: the visual abstract

swapnil hiremath

December 5, 2023

Visual Abstract

A very colourful visual abstract from Sabarinath!